Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Hazard Ratio

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Study Designs in Epidemiology

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.

Bioequivalence studies: Biowaivers

Bioequivalence studies: Biowaivers

In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Changing Landscape of Journalology in Medicine.

Seminars in nuclear medicine·2019

Same author

Systematic reviews in restorative dentistry: discussing relevant aspects.

Journal of esthetic and restorative dentistry : official publication of the American Academy of Esthetic Dentistry ... [et al.]·2019

Same author

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2019

Same author

Guidance for reporting outcomes in clinical trials: scoping review protocol.

BMJ open·2019

Same author

Systematic reviews in dentistry: Current status, epidemiological and reporting characteristics.

Journal of dentistry·2019

Same author

Screening for depression in women during pregnancy or the first year postpartum and in the general adult population: a protocol for two systematic reviews to update a guideline of the Canadian Task Force on Preventive Health Care.

Systematic reviews·2019

Same journal

Compression therapies for the treatment of venous leg ulcers: a mixed method process evaluation in a randomised controlled trial, VenUS6.

Trials·2026

Same journal

Cheek acupuncture for enhancing postoperative recovery after endoscopic sinus surgery: study protocol for a pilot randomized controlled trial.

Trials·2026

Same journal

Methodological guidance for incorporating lived experience in the early stages of core outcome set development: a scoping review.

Trials·2026

Same journal

IMPACT-Introduction of Mycotic Prophylaxis At Cystectomy Trial: perioperative mycotic prophylaxis with fluconazole to reduce postoperative complications following cystectomy-study protocol for a national multi-center, double-blinded, placebo-controlled, randomized clinical trial.

Trials·2026

Same journal

Correction: The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trial.

Trials·2026

Same journal

A cluster randomized trial to evaluate the effects of a quality cluster-based intervention on the use of prostate-specific antigen test in general practice-a study protocol.

Trials·2026

See all related articles

Search research articles

Related Experiment Videos

CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials.

Kenneth F Schulz¹, Douglas G Altman, David Moher

¹Family Health International, Research Triangle Park, NC 27709, USA. kschulz@fhi.org

|March 26, 2010

Summary

This summary is machine-generated.

The CONSORT 2010 Statement provides updated guidelines for reporting randomized controlled trials. This ensures clearer, more accurate reporting of trial methodology and findings for researchers and readers.

Related Experiment Videos

Area of Science:

Clinical Trials Methodology
Evidence-Based Medicine
Scientific Reporting Standards

Background:

Randomized controlled trials (RCTs) are crucial for medical research.
Accurate reporting of RCTs is essential for reliable evidence synthesis.
Previous versions of the CONSORT statement have guided trial reporting globally.

Framework:

The CONSORT 2010 Statement is an updated reporting guideline for RCTs.
It incorporates new methodological evidence and practical experience.
The guideline aims to enhance the transparency and completeness of trial reporting.

Implementation:

The CONSORT 2010 checklist and explanation paper detail the updated recommendations.
Authors are encouraged to adhere to these updated reporting standards.
Dissemination efforts ensure widespread awareness and adoption of CONSORT 2010.

Implications:

Improved reporting quality of randomized controlled trials.
Enhanced ability for readers to assess the validity and generalizability of trial results.
Facilitation of evidence-based decision-making in healthcare and policy.